Bioptik Technology (4161) — Cash Flow Quality Index
Bioptik Technology (4161) has a Cash Flow Quality Index of 2.03x as of December 2025. Operating cash flow of NT$53.21 Million exceeds net income of NT$26.24 Million, indicating high earnings quality where cash backs reported profits. Also explore total assets of Bioptik Technology for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Bioptik Technology Cash Flow Quality Index (2018–2025)
Historical Cash Flow Quality Index for Bioptik Technology across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how tangible is Bioptik Technology's equity to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Bioptik Technology (2018–2025)
Year-by-year earnings quality comparison for Bioptik Technology. For live market cap and the full company financial profile, see market value of Bioptik Technology.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.84x | NT$59.99 Million | NT$71.19 Million | ▼ -50.4% |
| 2024 | 1.70x | NT$158.82 Million | NT$93.57 Million | ▼ -12.3% |
| 2023 | 1.93x | NT$205.95 Million | NT$106.47 Million | ▲ +120.7% |
| 2022 | 0.88x | NT$55.06 Million | NT$62.81 Million | ▲ +141.8% |
| 2021 | -2.10x | NT$-41.15 Million | NT$19.62 Million | ▼ -126.8% |
| 2019 | 7.81x | NT$41.03 Million | NT$5.25 Million | ▲ +393.0% |
| 2018 | 1.59x | NT$41.83 Million | NT$26.39 Million | — |